Annual Congress Copenhagen 2005

Saturday, 17.09.2005
Sunday, 18.09.2005
Monday, 17.09.2005
Tuesday, 20.09.2005
Wednesday, 21.09.2005

Citations should be made in the following way: Authors. Title. Eur Respir J 2005; 26: Suppl. 49, abstract number.

Material from 2005:

4063 Abstracts
739 Slide presentations
213 Webcasts
93 Handouts

Material from 2005: Show

Biological agents in the therapy of sarcoidosis

Hot topics
Chairs: M. Spiteri (Stoke-on-Trent, United Kingdom), R. P. Baughman (Cincinnati, United States of America)
Aims: Based on our current understanding of the immunopathogenesis of sarcoidosis, this symposium will give an update on latest developments in identifying alternative drugs to reduce steroid-related side-effects in sarcoidosis. Promising molecules are biological agents targeted on the selective inhibition of TNF-α, the major cytokine in the induction of granuloma formation. The results of a randomised, double blind trial with a TNF-α antagonist for chronic pulmonary sarcoidosis will be presented.

Download all media

Standard therapy for sarcoidosis U. Costabel (Essen, Germany)
Results of a randomized, double blind trial of anti-tumor necrosis antibody for sarcoidosis R. P. Baughman (Cincinnati, United States of America)
The future of targeted therapies for sarcoidosis C. Agostini (Padova, Italy)